Sativex® in multiple sclerosis spasticity: a cost–effectiveness model
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Health Policy,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1586/erp.12.40
Reference36 articles.
1. The epidemiology of multiple sclerosis in Europe
2. What drives quality of life in multiple sclerosis?
3. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the ‘5E’ study
4. Assessment of Caregiver Burden in Families of Persons with Multiple Sclerosis
5. Estimation of the cost of MS in Europe: Extrapolations from a multinational cost study
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations;Value in Health;2021-10
2. Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses;The European Journal of Health Economics;2021-04-20
3. Can Medical Cannabis Therapies be Cost-Effective in the Non-Surgical Management of Chronic Knee Pain?;Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders;2021-01
4. Modelling expenses for multiple sclerosis treatment;Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology);2020-06-01
5. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis;Clinical Drug Investigation;2020-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3